Biomerieux (BIM) EUR1

Sell:€115.90Buy:€117.30€0.90 (0.78%)

Prices delayed by at least 15 minutes
Sell:€115.90
Buy:€117.30
Change:€0.90 (0.78%)
Deal now
Prices delayed by at least 15 minutes
Sell:€115.90
Buy:€117.30
Change:€0.90 (0.78%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.

Key people

Alexandre Merieux
Chairman of the Board
Pierre Boulud
Chief Executive Officer, Member of the Executive Board
Guillaume Bouhours
Chief Financial Officer, Executive Vice President - Purchasing and Information Systems, Member of the Executive Committee
Audrey Dauvet
Executive Vice President - Legal Corporate Integrity and Public Affairs, General Counsel, Member of the Executive Committee
Valerie Leylde
Executive Vice President - Human Resources, Communication and CSR, Member of the Executive Committee
Pierre Charbonnier
Executive Vice President - Global Quality, Manufacturing and Supply Chain, Member of the Executive Committee
Charles K. Cooper
Executive Vice President, Chief Medical Officer, Member of the Executive Committee
Yasha Mitrotti
Executive Vice President - Industrial Microbiology, Member of the Executive Committee
Jennifer Zinn
Executive Vice President - Clinical Operations, Member of the Executive Committee
Celine Roger-Dalbert
Executive Director - Research and Development, Member of the Executive Committee
Philippe Archinard
Non-Independent Director
Jean-Luc Belingard
Non-Independent Director
Harold Boeel
Non-Independent Director
Marie-Helene Habert-Dassault
Non-Independent Director
Sylvain Orenga
Director - Representing Employees
Click to see more

Key facts

  • EPIC
    -
  • Location
    France
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    FR0013280286
  • Market cap
    €13.73bn
  • Employees
    14,651
  • Shares in issue
    118.36m
  • Exchange
    Euronext Paris
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.